EMAIL THIS PAGE TO A FRIEND
SML0150 Sigma

Tolcapone

≥98% (HPLC)

Synonym: 3,4-Dihydroxy-4′-methyl-5-nitrobenzophenone, Ro 40-7592

Purchase

Properties

Related Categories Approved Therapeutics/Drug Candidates, Bioactive Small Molecule Alphabetical Index, Bioactive Small Molecules, Catechol-O-methyltransferase, Cell Biology,
InChI Key   MIQPIUSUKVNLNT-UHFFFAOYSA-N
assay   ≥98% (HPLC)
form   powder
storage condition   desiccated
color   yellow
solubility   DMSO: ≥15 mg/mL
originator   Roche
storage temp.   2-8°C

Description

Packaging

10, 50 mg in glass bottle

Application

Tolcapone may be used in COMT-mediated cell signaling studies.

Biochem/physiol Actions

Inhibition of catechol-O-methyltransferase by tolcapone increases the half-life and bioavailabilty of levodopa. It therefore is an effective adjunctive therapy in patients with Parkinson′s disease with motor response fluctuations.

Tolcapone is an orally active catechol-O-methyltransferase (COMT) inhibitor. It inhibits both central and peripheral COMT. Tolcapone crosses the blood-brain barrier, and has been used for L-DOPA adjunct therapy in the treatment of Parkinson′s Disease.

Features and Benefits

This compound was developed by Roche. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Safety & Documentation

Safety Information

Symbol 
GHS09  GHS09
Signal word 
Warning
Hazard statements 
Precautionary statements 
RIDADR 
UN 3077 9 / PGIII
RTECS 
PC4952500

Documents

Certificate of Analysis


Discover your Target

Making Headway
Protocols & Articles
Peer-Reviewed Papers
15

References

Related Products

Technical Service:

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Bulk Ordering & Pricing:

Need larger quantities for your development, manufacturing or research applications?